Mostrando 2 resultados de: 2
Origen
scopus(2)
Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin
ArticleAbstract: The majority of Mexican patients with diabetes mellitus type 2 (DMT2) (67.9-85.0%) are prescribed suPalabras claves:Cytochrome P450 2C9, DIABÉTES, Glibenclamide, Glycated hemoglobin A1c, MetforminAutores:Adrián LLerena, Castillo-Nájera F., Cuautle-Rodríguez P., de Andrés F., Molina-Guarneros J.A., Rodríguez-Rivera N.S.Fuentes:scopusPresent status and perspective of pharmacogenetics in Mexico
ReviewAbstract: Drug costs account for up to 24% of the country's health expenditure and there are 13,000 registeredPalabras claves:Cytochrome p450, Drug-metabolizing enzymes, Interindividual variability, pharmacogenetics, Phenotyping cocktailsAutores:Adrián LLerena, Cuautle-Rodríguez P., Molina-Guarneros J.A.Fuentes:scopus